Moderna’s mRESVIA FDA approval paves way for mRNA vaccines across multiple indications: GlobalData
The drug will be the third prophylactic RSV vaccine to enter the US market following the launches of GSK’s Arexvy and Pfizer’s…
Recover your password.
A password will be e-mailed to you.
Recover your password.
A password will be e-mailed to you.